<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr Lalchandani Labs Ltd has submitted its annual disclosure to BSE confirming that it does not qualify as a 'Large Corporate' under SEBI Circular dated November 26, 2018. The company stated that its long-term borrowings as on March 31, 2025 are below the Rs. 1,000 crore threshold required for Large Corporate classification. The disclosure was signed by Managing Director Arjan Lalchandani (DIN: 07873508). The filing is a routine compliance requirement applicable to all listed entities, irrespective of whether they meet the threshold.
This is a routine regulatory filing with no material impact on shareholders or the stock price. It simply confirms that the company is below the large corporate borrowing threshold and therefore not subject to the mandatory incremental borrowing or debt security disclosure obligations under the SEBI framework.